Trial Profile
Phase II Study of Clofarabine in Combination With Low Dose Cytarabine for Untreated Patients With Poor Risk Myelodysplastic Syndromes
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary) ; Cytarabine (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- 30 Sep 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 03 Mar 2011 New trial record